Elevai Labs (ELAB) said Thursday that its Elevai Biosciences subsidiary filed two patent applications for its lead candidate, EL-22, to treat muscle loss in obese patients.
Shares surged 52% as intraday trading volume soared to over 477.4 million from a daily average of about 4.9 million.
EVgo (EVGO) said Thursday it has received a conditional commitment for a loan guarantee of up to $1.05 billion from the US Department of Energy to expand its fast charging network.
Shares soared 59% as intraday trading volume catapulted to more than 100.2 million from a daily average of about 3.39 million.
RBC Capital raised its price target on Vistra (VST) to $141 from $105 while keeping its outperform rating.
Shares of Vistra climbed 6.8%, with intraday trading volume at over 10.3 million compared with a daily average of about 6.9 million.
Price: 0.13, Change: +0.04, Percent Change: +51.53
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。